Skip to contentB
BioCorRx Inc.
B
BICXBioCorRx Inc. Q4 2019 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$62.45K$62.45Kderived+20.8% vs Q4 2018 Net Income-$1.20M-$1.20MderivedN/M vs Q4 2018 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Operating Incomederived-$1,595,357N/M Operating Cash Flowderived-$889,162N/M Free Cash Flowderived-$944,130N/M Margins · derivedOperating margin-2554.7%+1208.3 pt vs Q4 2018
Net margin-1926.5%+2862.2 pt vs Q4 2018
ended Dec 31, 2019 · filed Mar 30, 2020 · 90 d after period end